Production (Stage)
Ernexa Therapeutics Inc.
ERNA
$2.29
-$0.08-3.38%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.92M | 1.73M | 4.26M | 2.59M | 5.12M |
| Total Receivables | 156.00K | 437.00K | 187.00K | 228.00K | 351.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 137.00K | 186.00K | 279.00K | 769.00K | 697.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2.21M | 2.35M | 4.73M | 3.58M | 6.16M |
|
|
|||||
| Total Current Assets | 2.21M | 2.35M | 4.73M | 3.58M | 6.16M |
| Net Property, Plant & Equipment | 686.00K | 755.00K | 824.00K | 36.64M | 37.23M |
| Long-term Investments | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M |
| Goodwill | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 118.00K | 118.00K | 120.00K | 4.22M | 4.22M |
| Total Assets | 5.06M | 5.27M | 7.72M | 46.49M | 49.66M |
|
|
|||||
| Total Accounts Payable | 1.28M | 1.72M | 2.19M | 2.19M | 2.06M |
| Total Accrued Expenses | 1.35M | 1.01M | 1.73M | 2.17M | 2.16M |
| Short-term Debt | 2.25M | -- | 4.93M | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 213.00K | 207.00K | 201.00K | 4.27M | 2.87M |
| Total Finance Division Other Current Liabilities | 5.35M | 3.00K | 907.00K | 968.00K | 675.00K |
| Total Other Current Liabilities | 5.35M | 3.00K | 907.00K | 968.00K | 675.00K |
| Total Current Liabilities | 10.44M | 2.94M | 9.95M | 9.60M | 7.77M |
|
|
|||||
| Total Current Liabilities | 10.44M | 2.94M | 9.95M | 9.60M | 7.77M |
| Long-Term Debt | -- | -- | 32.04M | 8.90M | 8.01M |
| Short-term Debt | 2.25M | -- | 4.93M | -- | -- |
| Capital Leases | 419.00K | 477.00K | 534.00K | 36.04M | 36.57M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 152.00K | 153.00K | 10.59M | 473.00K | 722.00K |
| Total Liabilities | 11.01M | 3.57M | 53.11M | 55.01M | 53.07M |
|
|
|||||
| Common Stock & APIC | 233.79M | 233.24M | 180.38M | 190.64M | 190.22M |
| Retained Earnings | -239.74M | -231.54M | -225.77M | -199.17M | -193.63M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -5.95M | 1.70M | -45.39M | -8.53M | -3.41M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
|
|
|||||
| Total Common Equity | -5.95M | 1.70M | -45.39M | -8.53M | -3.41M |
| Total Preferred Equity | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.95M | 1.70M | -45.39M | -8.53M | -3.41M |
|
|
|||||